Smart Nanosensitizers for Activatable Sono‐Photodynamic Immunotherapy of Tumors by Redox‐Controlled Disassembly
Angewandte Chemie International Edition · 2023
DOI: 10.1002/anie.202217055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2023. Verfasst von Lingjun Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research and Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Sha…. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Tumor‐targeted and stimuli‐activatable nanosensitizers are highly desirable for cancer theranostics. However, designing smart nanosensitizers with multiple imaging signals and synergistic therapeutic activities switched on is challenging. Herein, we report tumor‐targeted and redox‐activatable nanosensitizers ( 1‐NPs ) for sono‐photodynamic immunotherapy of tumors by molecular co‐assembly and redox‐controlled disassembly. 1‐NPs show a high longitudinal relaxivity ( r 1 =18.7±0.3 mM −1 s −1 ), but “off” dual fluorescence (FL) emission (at 547 and 672 nm), “off” sono‐photodynamic therapy and indoleamine 2,3‐dioxygenase 1 (IDO1) inhibition activities. Upon reduction by glutathione (GSH), 1‐NPs rapidly disassemble and remotely release small molecules 2‐Gd , Zn‐PPA‐SH and NLG919, concurrently switching on (1) dual FL emission, (2) sono‐photodynamic therapy and (3) IDO1 inhibition activities. After systemic injection, 1‐NPs are effective for bimodal FL and magnetic resonance (MR) imaging‐guided sono‐photodynamic immunotherapy of orthotropic breast and brain tumors in mice under combined ultrasound (US) and 671‐nm laser irradiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research and Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing, 210023, China.
- State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.
ORCID-Profile: Deju Ye
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Jiangsu Province
- State Key Laboratory of Analytical Chemistry for Life Sciences
Zitieren
APA
Liu, L., Zhang, J., An, R., Xue, Q., Cheng, X., Hu, Y., Huang, Z., Wu, L., Zeng, W., Miao, Y., Li, J., Zhou, Y., Chen, H. Y., Liu, H., & Ye, D. (2023). Smart Nanosensitizers for Activatable Sono‐Photodynamic Immunotherapy of Tumors by Redox‐Controlled Disassembly. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202217055
Vancouver
Liu L, Zhang J, An R, Xue Q, Cheng X, Hu Y, et al. Smart Nanosensitizers for Activatable Sono‐Photodynamic Immunotherapy of Tumors by Redox‐Controlled Disassembly. Angewandte Chemie International Edition. 2023. doi:10.1002/anie.202217055
BibTeX
@article{Liu2023,
author = {Liu, Lingjun and Zhang, Junya and An, Ruibing and Xue, Qi and Cheng, Xi and Hu, Yuxuan and Huang, Zheng and Wu, Luyan and Zeng, Wenhui and Miao, Yinxing and Li, Jie and Zhou, Yu and Chen, Hong-Yuan and Liu, Hong and Ye, Deju},
title = {Smart Nanosensitizers for Activatable Sono‐Photodynamic Immunotherapy of Tumors by Redox‐Controlled Disassembly},
journal = {Angewandte Chemie International Edition},
year = {2023},
doi = {10.1002/anie.202217055}
}
EUVIMED